E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
The latest regulatory milestones strengthen Medtronic’s cardiac ablation portfolio by adding enhanced mapping and real-time tissue-proximity capabilities to its Affera and PulseSelect platforms.
imphoenix82
CeleCor’s Zalunfiban is a subcutaneously injected inhibitor of the platelet glycoprotein (GP) IIb/IIIa receptor designed for rapid pre-hospital treatment of STEMI heart attacks.
imphoenix82
Under the proposed agreement, Healthcare Triangle and AI World intend to form a joint venture that would hold the intellectual property and distribution rights for the AI-enabled humanoid nursing robots in North America.
imphoenix82
Regeneron to receive USD 1 billion upfront payment from Sanofi, with potential for up to an additional USD 7 billion in future milestone payments.
imphoenix82
Organised under the theme “Transforming Gastrointestinal Health, Preserving Nature,” WCOG 2026 will continue till 3 October 2026.
imphoenix82
Egetis’ Emcitate is the first and only approved treatment for MCT8 deficiency, with marketing authorisations in the EU and the US.
imphoenix82
According to court documents, between July 2023 and April 2024, the two Indian nationals allegedly obtained counterfeit Ozempic from unauthorised sources in China and distributed the products in the US.
imphoenix82
Seven countries — Angola, Bangladesh, the Democratic Republic of the Congo (DRC), Nigeria, South Sudan, Sudan and Yemen — accounted for around 90% of all reported cholera cases and deaths globally.
imphoenix82
Novo Nordisk has licensed HRS-1596, a Phase 1-ready oral GLP-1/GIP dual agonist from Hengrui Pharma, in a deal worth up to $2.6 billion, while new real-world data linked semaglutide 2 mg with a lower risk of major adverse cardiovascular events than switching to tirzepatide
imphoenix82
According to Akums, the approval of Colchicine 0.5 mg Tablets marks a first-time-in-India regulatory milestone for this application.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
